Aegerion Pharmaceuticals, Inc. (AEGR) Actualités

Unknown (sec Staff)

Amended Application for Qualification of Trust Indentures (t-3/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   Amendment No. 1...

Application for Qualification of Trust Indentures (t-3)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   FORM...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange...

Amended Statement of Ownership (sc 13g/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549  ...

Amended Statement of Ownership (sc 13g/a)

SCHEDULE 13G Amendment No. 6 AEGERION PHARMACEUTICALS INC COMMON STOCK Cusip #00767E102 Check the appropriate box to...

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the...

Statement of Changes in Beneficial Ownership (4)

FORM 4 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...

Amended Statement of Beneficial Ownership (sc 13d/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES...

Amended Statement of Beneficial Ownership (sc 13d/a)

  SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 SCHEDULE 13D Under the...

Current Report Filing (8-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...